论文部分内容阅读
杂交瘤技术的发展为大量制备“单克隆抗体”提供了重要手段。放射性核素标记的“单克隆抗体”是肿瘤显像和治疗的良好药物。虽然有些尚待解决的问题,但它的深入研究,必将给肿瘤的早期诊断和治疗带来曙光。
The development of hybridoma technology provides an important means for the large-scale preparation of “monoclonal antibodies”. Radionuclide labeled “monoclonal antibodies” are good drugs for tumor imaging and treatment. Although some problems remain to be solved, its in-depth study will surely bring dawn to the early diagnosis and treatment of tumors.